Baker Bros. Advisors’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.1M Sell
734,397
-1,588,259
-68% -$51.4M 0.13% 49
2025
Q4
$80.6M Hold
2,322,656
0.47% 29
2025
Q3
$84.4M Hold
2,322,656
0.61% 21
2025
Q2
$72.9M Hold
2,322,656
0.71% 19
2025
Q1
$68.9M Buy
2,322,656
+807,338
+53% +$24.2M 0.76% 16
2024
Q4
$44.7M Hold
1,515,318
0.48% 26
2024
Q3
$47.2M Hold
1,515,318
0.49% 25
2024
Q2
$51.4M Hold
1,515,318
0.66% 24
2024
Q1
$98.5M Sell
1,515,318
-1,005,413
-40% -$69M 1.24% 11
2023
Q4
$172M Hold
2,520,731
1.96% 7
2023
Q3
$131M Hold
2,520,731
0.75% 9
2023
Q2
$151M Hold
2,520,731
0.87% 7
2023
Q1
$125M Hold
2,520,731
0.68% 7
2022
Q4
$144M Hold
2,520,731
0.86% 10
2022
Q3
$118M Buy
2,520,731
+1
+0% +$48 0.77% 11
2022
Q2
$94M Hold
2,520,730
0.53% 14
2022
Q1
$75.4M Hold
2,520,730
0.43% 19
2021
Q4
$86.3M Hold
2,520,730
0.42% 21
2021
Q3
$93.4M Hold
2,520,730
0.41% 20
2021
Q2
$98.4M Hold
2,520,730
0.43% 21
2021
Q1
$107M Buy
+2,520,730
New +$112M 0.47% 19

Other funds holding IMCR